1.646.889.1200|info@lifescipublicrelations.com

Diasome’s Liver Targeted Insulin

//Diasome’s Liver Targeted Insulin

Diasome’s Liver Targeted Insulin

We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin to the liver where it can substantially improve T1D glucose control.

By | 2019-04-18T16:41:04-04:00 April 18th, 2019|News|Comments Off on Diasome’s Liver Targeted Insulin

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.